Medication info
Risend Tablet 150 mg (Risedronate Sodium 2.5 Hydrate)

Risend Tablet 150 mg (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›172.1mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
Bright blue oblong film-coated tablet
Packaging
1 tablet/PTP
Approval status
Active

MFDS item code 201501058 · Approved 2015.02.27 · Insurance code 649404730

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
1. Adults: Administer 150 mg of risedronate sodium orally once monthly. 2. Older adults: No dose adjustment is necessary in older adults (over 60 years of age), as the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary for patients with creatinine clearance of 30 mL/min or more. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with plenty of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, take it as follows. - If the next scheduled dose is 7 days or more away, take 1 tablet the next morning after remembering. Take the next dose on the originally scheduled day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dose is within 7 days, wait until the originally scheduled day and then take 1 tablet.
Child dose
The safety and efficacy of this medicine in children under 18 years of age have not been established.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat and prevent osteoporosis that is likely to occur in postmenopausal women.

How to take

Adult dose

1. Adults: Administer 150 mg of risedronate sodium orally once monthly. 2. Older adults: No dose adjustment is necessary in older adults (over 60 years of age), as the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary for patients with creatinine clearance of 30 mL/min or more. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with plenty of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, take it as follows. - If the next scheduled dose is 7 days or more away, take 1 tablet the next morning after remembering. Take the next dose on the originally scheduled day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dose is within 7 days, wait until the originally scheduled day and then take 1 tablet.

Child dose

The safety and efficacy of this medicine in children under 18 years of age have not been established.

Precautions

This medication can irritate the stomach and esophagus, so patients with upper gastrointestinal diseases such as gastritis, esophagitis, or esophageal ulcers should take it with caution. Patients with esophageal issues, slow esophageal transit, hypocalcemia, pregnant or breastfeeding women, and those with severe renal impairment should not take this medication. When taking, it should be taken with a sufficient amount of water, and one should not lie down for at least 30 minutes after taking. A time interval should be maintained before and after meals. This medication may interfere with absorption if taken with drugs or foods containing divalent cations like calcium or magnesium, so caution is advised. Rarely, serious side effects such as osteonecrosis of the jaw and atypical femoral fractures may occur with long-term use, so any unusual symptoms should be immediately discussed with a doctor. It is important to intake adequate calcium and vitamin D, especially in cases of parathyroid dysfunction or vitamin D deficiency where treatment should be mandatory before taking this medication. Pregnant women or those who may become pregnant, as well as breastfeeding women, should avoid taking this medication and consult a physician if necessary. Safety for children has not been established, so it is advisable not to use it for those under 18 years of age. The elderly can use this medication similarly to other adults without special precautions, but should promptly inform medical staff of any adverse reactions. Overdose may lead to hypocalcemia, whereby symptoms should warrant immediate visit to a medical institution for appropriate treatment. This medication should be kept out of reach of children, and transferring it to other containers is not recommended to maintain quality.

Side effects

Esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, bleeding, upper gastrointestinal mucosal irritation, gastric ulcer, duodenal ulcer, dyspepsia, diarrhea, nausea, abdominal pain, vomiting, constipation, allergic reaction, peripheral edema, arthralgia, arthritis, bone fracture, joint abnormality, myalgia, bone pain, dizziness, depression, insomnia, bronchitis, sinusitis, rhinitis, pharyngitis, increased cough, rash, skin reaction, mucous membrane syndrome, toxic epidermal necrolysis, angioedema, blister, cataract, urinary tract infection, uveitis, scleritis, iritis, liver dysfunction, jaundice, loss of appetite, asthenia, heartburn, epigastric pain, discomfort in the chest, palpitations, increased sweating, facial flushing, warmth sensation, kidney stones, belching, hematuria, fever, eye pain, jaw necrosis, acute phase reaction, hypocalcemia, atypical fracture, osteonecrosis of the external auditory canal

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, preferably at a temperature between 1 and 30 degrees Celsius. Storing this way helps maintain the effectiveness and avoid deterioration of the medication.

Appearance and packaging

Appearance

Bright blue oblong film-coated tablet

Package unit

1 tablet/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.